ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,227Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 315

$781K Total Retail Price of All Prescriptions

Rank: 25 out of 315

460 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,177 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LOSARTAN POTASSIUM 649 626 1 4
LOVASTATIN 604 553 2 8
AMLODIPINE BESYLATE 472 450 3 2
LEVOTHYROXINE SODIUM 390 349 4 6
OMEPRAZOLE 347 329 5 9
LISINOPRIL 330 272 6 3
SIMVASTATIN 303 287 7 1
ATORVASTATIN CALCIUM 292 278 8 5
DONEPEZIL HCL 272 272 9 28
METFORMIN HCL 242 203 10 7
METOPROLOL SUCCINATE 239 220 11 13
FUROSEMIDE 232 222 12 15
NAMENDA 223 223 13 38
RANITIDINE HCL 185 158 14 42
ATENOLOL 180 139 15 11
ALLOPURINOL 178 164 16 14
DIOVAN 155 143 17 27
METOPROLOL TARTRATE 132 108 18 18
ESCITALOPRAM OXALATE 124 124 19 108
POTASSIUM CHLORIDE 124 93 19 36
CLOPIDOGREL 119 107 21 25
LOSARTAN-HYDROCHLOROTHIAZIDE 115 114 22 17
GLIMEPIRIDE 113 101 23 32
ALENDRONATE SODIUM 99 88 24 12
HYDROCHLOROTHIAZIDE 92 85 25 16
TRAMADOL HCL 85 73 26 59
MIRTAZAPINE 81 81 27 68
GABAPENTIN 81 70 27 37
SERTRALINE HCL 80 80 29 100
PLAVIX 79 75 30 40
ZOLPIDEM TARTRATE 79 78 30 29
HYDROCODONE-ACETAMINOPHEN 77 73 S3 32 19
LEVETIRACETAM 76 76 33 189
PREDNISONE 74 71 34 41
TAMSULOSIN HCL 74 62 34 21
CIPROFLOXACIN HCL 73 67 36 58
DIGOXIN 69 68 37 45
CARVEDILOL 67 62 38 22
AZITHROMYCIN 65 59 39 39
NIFEDIAC CC 62 62 40 97
PANTOPRAZOLE SODIUM 62 61 40 35
ADVAIR DISKUS 61 59 42 46
TRAZODONE HCL 60 60 43 93
NIFEDIPINE ER 57 48 44 67
LACTULOSE 56 50 45 115
EVISTA 55 54 46 48
LANTUS 53 39 47 113
LATANOPROST 53 53 47 321
RIVASTIGMINE 53 53 47 252
TRICOR 53 44 47 130
HYDRALAZINE HCL 52 52 51 98
CHLORTHALIDONE 52 39 51 154
LANTUS SOLOSTAR 51 34 53 69
MUPIROCIN 50 43 54 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.